|
|
.
See Category: Diseases of the genitourinary system
See Header: Other specified disorders of bladder
ICD-10 (CM) Code and Descriptor
|
N32.89 |
Other specified disorders of bladder
|
N3289 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 20.08%
|
25.54%
|
19.30%
|
11.66%
|
6.85%
|
4.41%
|
2.95%
|
2.14%
|
1.51%
|
1.21%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for N32.89*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
4,352
|
4,376
|
|
87086
|
URINE CULTURE/COLONY COUNT |
4,320
|
4,337
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
4,278
|
395,142
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
4,131
|
4,160
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
4,086
|
4,102
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
3,704
|
3,711
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
3,319
|
79,918
|
|
J3010
|
FENTANYL CITRATE INJECTION |
3,306
|
4,692
|
|
J2405
|
ONDANSETRON HCL INJECTION |
3,159
|
13,171
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
3,012
|
9,983
|
|
52000
|
CYSTOURETHROSCOPY |
2,717
|
2,717
|
|
80048
|
METABOLIC PANEL TOTAL CA |
2,575
|
2,582
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2,548
|
2,550
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
2,395
|
3,451
|
|
74178
|
CT ABD&PLV WO CNTR FLWD CNTR |
2,343
|
2,343
|
|
81003
|
URINALYSIS AUTO W/O SCOPE |
2,014
|
2,018
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
1,942
|
7,946
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
1,814
|
11,756
|
|
88112
|
CYTOPATH CELL ENHANCE TECH |
1,803
|
1,886
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
1,693
|
1,694
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
N32.89 related to the following DRG Codes:
698-700
|
